BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19291220)

  • 1. Towards a therapy for Huntington's disease (Commentary on Giampà et al.).
    Hannan AJ
    Eur J Neurosci; 2009 Mar; 29(5):901. PubMed ID: 19291220
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
    Giampà C; Middei S; Patassini S; Borreca A; Marullo F; Laurenti D; Bernardi G; Ammassari-Teule M; Fusco FR
    Eur J Neurosci; 2009 Mar; 29(5):902-10. PubMed ID: 19291221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental therapeutics in transgenic mouse models of Huntington's disease.
    Beal MF; Ferrante RJ
    Nat Rev Neurosci; 2004 May; 5(5):373-84. PubMed ID: 15100720
    [No Abstract]   [Full Text] [Related]  

  • 4. The R6 lines of transgenic mice: a model for screening new therapies for Huntington's disease.
    Gil JM; Rego AC
    Brain Res Rev; 2009 Mar; 59(2):410-31. PubMed ID: 19118572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical considerations in gene therapy of Huntington's disease.
    MacMillan JC; Snell RG; Harper PS
    Gene Ther; 1994; 1 Suppl 1():S88. PubMed ID: 8542434
    [No Abstract]   [Full Text] [Related]  

  • 6. Fly models of Huntington's disease.
    Marsh JL; Pallos J; Thompson LM
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R187-93. PubMed ID: 12925571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving toward a gene therapy for Huntington's disease.
    Glorioso JC; Cohen JB; Carlisle DL; Munoz-Sanjuan I; Friedlander RM
    Gene Ther; 2015 Dec; 22(12):931-3. PubMed ID: 26633828
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of Huntington's disease on the human and mouse proteome.
    Zabel C; Klose J
    Int Rev Neurobiol; 2004; 61():241-83. PubMed ID: 15482818
    [No Abstract]   [Full Text] [Related]  

  • 9. Huntington's disease.
    Stipe J; White D; Van Arsdale E
    Am J Nurs; 1979 Aug; 79(8):1428-32. PubMed ID: 157071
    [No Abstract]   [Full Text] [Related]  

  • 10. Huntington's disease: a monogenic disorder with cellular and biochemical complexities.
    Bhattacharyya NP
    FEBS J; 2008 Sep; 275(17):4251. PubMed ID: 18637948
    [No Abstract]   [Full Text] [Related]  

  • 11. Huntington's disease and neurogenesis: FGF-2 to the rescue?
    La Spada AR
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):17889-90. PubMed ID: 16330780
    [No Abstract]   [Full Text] [Related]  

  • 12. [Huntington's disease--review on neuroscientific approaches].
    Kanazawa I
    Tanpakushitsu Kakusan Koso; 1984 Dec; 29(14):1815-25. PubMed ID: 6241961
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.
    Sadan O; Shemesh N; Cohen Y; Melamed E; Offen D
    Isr Med Assoc J; 2009 Apr; 11(4):201-4. PubMed ID: 19603590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reserpine (serpasin) in therapy of Huntington's chorea].
    ZMORSKI T
    Psychiatr Neurol (Basel); 1959 Jan; 137(1):40-8. PubMed ID: 13634263
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct neuroinflammatory profile in post-mortem human Huntington's disease.
    Silvestroni A; Faull RL; Strand AD; Möller T
    Neuroreport; 2009 Aug; 20(12):1098-103. PubMed ID: 19590393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Huntington's disease].
    Heiberg A
    Tidsskr Nor Laegeforen; 2008 Oct; 128(19):2214-7. PubMed ID: 18846148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of tetrathiomolybdate in the R6/2 model of Huntington disease.
    Tallaksen-Greene SJ; Janiszewska A; Benton K; Hou G; Dick R; Brewer GJ; Albin RL
    Neurosci Lett; 2009 Mar; 452(1):60-2. PubMed ID: 19429000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current clinical management of Huntington's disease.
    Phillips W; Shannon KM; Barker RA
    Mov Disord; 2008 Aug; 23(11):1491-504. PubMed ID: 18581443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial function in Huntington's disease: clues for pathogenesis and prospects for treatment.
    Schapira AH
    Ann Neurol; 1997 Feb; 41(2):141-2. PubMed ID: 9029061
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Huntington's disease.
    Whittier JR
    Mod Treat; 1968 Mar; 5(2):332-50. PubMed ID: 4231805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.